Hengrui Therapeutics Overview
- Status
-
Private
- Latest Deal Type
-
Corporate
- Financing Rounds
-
1
Hengrui Therapeutics General Information
Description
Operator of a biopharmaceutical company. The company is engaged in the development and commercialization of cancer therapies. Its therapeutic areas of focus are oncology and endocrinology, with multiple clinical-stage assets for oncology/immuno-oncology and diabetes/weight loss.
Contact Information
Website
www.hengruitx.com
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
- 506 Carnegie Center
- Suite 102
- Princeton, NJ 08540
- United States
+1 (609) 000-0000
Hengrui Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Hengrui Therapeutics Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Adam Zong Ph.D | President & Chief Executive Officer |
Hengrui Therapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|